Hironori Tanaka

12PUBLICATIONS
34CO-AUTHORS
English languagePredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Behavioural epidemiologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Oct 04, 2025
Employment Status of Patients With Liver Disease: A Nationwide Questionnaire Survey in Japan.

Yoshio Tokumoto, Yoichi Hiasa, Yoshihito Uchida

|May 28, 2025
A novel approach to evaluate the therapeutic efficacy of durvalumab and tremelimumab combination therapy in hepatocellular carcinoma.

Tetsu Tomonari, Shigeo Shimose, Issei Saeki

|May 07, 2025
Impact of muscle volume changes following atezolizumab-bevacizumab therapy in patients with unresectable hepatocellular carcinoma.

Hironori Ochi, Joji Tani, Tetsu Tomonari

|Oct 07, 2024
Initial treatment efficacy and safety of durvalumab plus tremelimumab combination therapy in unresectable hepatocellular carcinoma in clinical practice.

Tetsu Tomonari, Joji Tani, Yasushi Sato

Pageof 2